Literature DB >> 15160946

Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V.

Friedrich Wimazal1, Josef Schwarzmeier, Karl Sotlar, Ingrid Simonitsch, Wolfgang R Sperr, Robert Fritsche-Polanz, Manuela Födinger, Jörg Schubert, Hans-Peter Horny, Peter Valent.   

Abstract

In the vast majority of patients with systemic mastocytosis (SM), the bone marrow is the primary extracutaneous site of disease. In addition to bone marrow involvement, other visceral organs such as the spleen, liver or the gastrointestinal tract, may also be affected. However, isolated involvement of a single extramedullary organ is rarely seen in SM. We report on two patients with SM with splenic involvement, lack of 'diagnostic' mast cell (MC) infiltrates in the bone marrow, and absence of skin lesions. In one patient, a myelodysplastic syndrome was diagnosed prior to the detection of SM. Both patients presented with massive splenomegaly and multifocal MC infiltrates in splenic tissues. These MCs also expressed CD25 as well as the C-KIT mutation D816V. In consecutive examinations, the mutation was also detected in the bone marrow in both patients suggesting diffuse infiltration with neoplastic cells. In summary, our data show that the spleen can be a primary site of disease in rare cases of SM. Mastocytosis should therefore be considered as a (rare) differential diagnosis in patients with splenomegaly of unknown etiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160946     DOI: 10.1080/1042819032000140979

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell Disease.

Authors:  Vito Sabato; Jack Chovanec; Margaretha Faber; Joshua D Milner; Didier Ebo; Jonathan J Lyons
Journal:  J Clin Immunol       Date:  2018-05-11       Impact factor: 8.317

Review 2.  KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Authors:  M Arock; K Sotlar; C Akin; S Broesby-Olsen; G Hoermann; L Escribano; T K Kristensen; H C Kluin-Nelemans; O Hermine; P Dubreuil; W R Sperr; K Hartmann; J Gotlib; N C P Cross; T Haferlach; A Garcia-Montero; A Orfao; J Schwaab; M Triggiani; H-P Horny; D D Metcalfe; A Reiter; P Valent
Journal:  Leukemia       Date:  2015-02-04       Impact factor: 11.528

3.  Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.

Authors:  Jacques P Zappulla; Patrice Dubreuil; Sabine Desbois; Sébastien Létard; Nadine Ben Hamouda; Marc Daëron; Georges Delsol; Michel Arock; Roland S Liblau
Journal:  J Exp Med       Date:  2005-12-13       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.